ClinicalTrials.Veeva

Menu

A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea

D

Duramed Research

Status and phase

Completed
Phase 2

Conditions

Amenorrhea

Treatments

Other: Placebo
Drug: DR-2021b
Drug: DR-2021a
Drug: DR-2021d
Drug: DR-2021c
Drug: DR-2021e

Study type

Interventional

Funder types

Industry

Identifiers

NCT00196391
DR-MPG-201

Details and patient eligibility

About

This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo and oral micronized progesterone in inducing withdrawal bleeding in women with secondary amenorrhea.

Full description

In this multicenter trial patients will be randomized to receive DR-2021, oral micronized progesterone, and placebo to evaluate the effects on withdrawal bleeding in women with secondary amenorrhea. Patients will be treated for 10 days and study participation will be approximately 24 days. Patients will undergo a physical exam including a pelvic and breast exam. Patients will be required to complete bleeding and spotting information daily in a diary.

Enrollment

180 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Not pregnant
  • Secondary amenorrhea or oligomenorrhea of at least 50 days duration
  • Not currently on any hormonal medication
  • Not at risk of pregnancy or willing to use a non-hormonal method of birth control during the study (ie, condom)

Exclusion criteria

  • Use an injectable or implantable estrogens, progestins, or androgens within the last 6 months
  • Use of any hormonal birth control within the last 3 months
  • Any contraindication to the use of progestins

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

180 participants in 6 patient groups, including a placebo group

1
Experimental group
Treatment:
Drug: DR-2021a
2
Experimental group
Treatment:
Drug: DR-2021b
3
Experimental group
Treatment:
Drug: DR-2021c
4
Experimental group
Treatment:
Drug: DR-2021d
5
Experimental group
Treatment:
Drug: DR-2021e
6
Placebo Comparator group
Treatment:
Other: Placebo

Trial contacts and locations

27

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems